Treace Medical Concepts, Inc.

UBS Group AG TMCI
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/5/2026
Shares
542,905
Value ($000)
727
Weight
0.0%
2021 Q2 - 2026 Q1 (20 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).